Tara Toone, TSLP - Medicare Speech-Language Pathologist in Gooding, ID

Tara Toone, TSLP is a medicare enrolled "Speech-language Pathologist" provider in Gooding, Idaho. Her current practice location is 202 14th Ave E, Gooding, Idaho. You can reach out to her office (for appointments etc.) via phone at (208) 734-7333.

Tara Toone is licensed to practice in Idaho (license number SLP-2100) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1326351198.

Contact Information

Tara Toone, TSLP
202 14th Ave E,
Gooding, ID 83330-1829
(208) 734-7333
Not Available



Healthcare Provider's Profile

Full NameTara Toone
GenderFemale
SpecialitySpeech-language Pathologist
Location202 14th Ave E, Gooding, Idaho
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1326351198
  • Provider Enumeration Date: 07/21/2010
  • Last Update Date: 06/16/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 0547433070
  • Enrollment ID: I20111028000500

Medical Identifiers

Medical identifiers for Tara Toone such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1326351198NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist SLP-2100 (Idaho)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Tara Toone allows following entities to bill medicare on her behalf.
Provider NamePrimary Therapy Source, Llc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1912027343
PECOS PAC ID: 7012002702
Enrollment ID: O20070926000529

News Archive

La Jolla Pharmaceutical, Adamis Pharmaceuticals to terminate merger agreement

La Jolla Pharmaceutical Company today announced that La Jolla and Adamis Pharmaceuticals Corporation have agreed to terminate their merger agreement relating to the proposed merger of the two companies.

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.

Scaling up access to maternal, child health care would prevent most deaths during pregnancy, childbirth

"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Computational adaptive optics for real-time in-vivo applications

Real-time, 3-D microscopic tissue imaging could be a revolution for medical fields such as cancer diagnosis, minimally invasive surgery and ophthalmology. University of Illinois researchers have developed a technique to computationally correct for aberrations in optical tomography, bringing the future of medical imaging into focus.

Read more Medical News

› Verified 2 days ago

Provider NameToone Inc.
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1083169023
PECOS PAC ID: 0840588893
Enrollment ID: O20161007000530

News Archive

La Jolla Pharmaceutical, Adamis Pharmaceuticals to terminate merger agreement

La Jolla Pharmaceutical Company today announced that La Jolla and Adamis Pharmaceuticals Corporation have agreed to terminate their merger agreement relating to the proposed merger of the two companies.

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.

Scaling up access to maternal, child health care would prevent most deaths during pregnancy, childbirth

"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Computational adaptive optics for real-time in-vivo applications

Real-time, 3-D microscopic tissue imaging could be a revolution for medical fields such as cancer diagnosis, minimally invasive surgery and ophthalmology. University of Illinois researchers have developed a technique to computationally correct for aberrations in optical tomography, bringing the future of medical imaging into focus.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tara Toone is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Tara Toone, TSLP
Po Box 596,
Gooding, ID 83330-0596

Ph: (208) 860-1340
Tara Toone, TSLP
202 14th Ave E,
Gooding, ID 83330-1829

Ph: (208) 734-7333

News Archive

La Jolla Pharmaceutical, Adamis Pharmaceuticals to terminate merger agreement

La Jolla Pharmaceutical Company today announced that La Jolla and Adamis Pharmaceuticals Corporation have agreed to terminate their merger agreement relating to the proposed merger of the two companies.

Nuvo Research provides details of new WF10 Phase 2 clinical trial for treatment of allergic rhinitis

Nuvo Research Inc., a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced additional details of its new Phase 2 clinical trial (the 2015 WF10 Trial) to assess WF10 for the treatment of allergic rhinitis.

Scaling up access to maternal, child health care would prevent most deaths during pregnancy, childbirth

"Every day, 800 women lose their lives giving birth - 287,000 each year - and the vast majority of these deaths occurs in developing countries. ... These deaths are unacceptable, particularly because they are preventable," the heads of the Health 4+ (UNAIDS, UNFPA, UNICEF, U.N. Women, the WHO, and the World Bank, known as H4+) write in the Huffington Post's "Global Motherhood" blog.

Study explores innovative approach to identifying successful treatment for HER2+ breast cancer

Ahmad M. Khalil, PhD, knew the odds were against him - as in thousands upon thousands to one. Yet he and his team never wavered from their quest to identify the parts of the body responsible for revving up one of the most aggressive forms of breast cancer, HER2+. This month in Breast Cancer Research and Treatment, Khalil and his colleagues at Case Western Reserve University proved the power of persistence; from a pool of more than 30,000 possibilities, they found 38 genes and molecules that most likely trigger HER2+ cancer cells to spread.

Computational adaptive optics for real-time in-vivo applications

Real-time, 3-D microscopic tissue imaging could be a revolution for medical fields such as cancer diagnosis, minimally invasive surgery and ophthalmology. University of Illinois researchers have developed a technique to computationally correct for aberrations in optical tomography, bringing the future of medical imaging into focus.

Read more News

› Verified 2 days ago


Speech-Language Pathologist in Gooding, ID

Marcella Louise Heil, M.S. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1735 South 1800 East, Gooding, ID 83330
Phone: 208-308-6500    
Cindy Howells,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 626 California St, Gooding, ID 83330
Phone: 208-316-2689    
Toone Inc.
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 442 Main St, Gooding, ID 83330
Phone: 208-725-3680    Fax: 208-595-2276
Erin Orloff,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 202 14th St Ave E, Gooding, ID 83330
Phone: 208-860-1340    
Lani Roemer, MS
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 202 14th Ave E, Gooding, ID 83330
Phone: 208-860-1340    Fax: 208-595-2276

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.